Asuragen Molecular Diagnostics Publications

An Amplification-based, Nanopore Carrier Screening Panel Resolves ClinicallyRelevant Variants in CFTR, SMN1/2, HBA1/2, HBB, and FMR1 in a Unified Workflow

Read More


Bradley Hall, Bryan Killinger, Christopher J. Fraher, Bradley Martin, Monica Roberts, Jonathan Turner, Pranesh Rao, Ryan Routsong, Gary J. Latham


Back To